Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • The Impact of AI on Clinical Trials: Four Key Benefits and Three Major Risks

    August 1, 2025 | AI, Patient Retention, clinical trials, patient recruitment 

    Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by streamlining the drug development process and helping to generate more robust data, which will inevitably aid regulatory decision-making.

    - PMLiVE

    Eloise Moffatt, our Vice President of Commercial, joined other industry experts during a webinar about AI trends and technologies for 2025. They discussed the benefits that AI and machine learning (ML) can bring to clinical trials and the potential pitfalls that require careful consideration.

    Read more here

    This content was provided by Innovative Trials

    Company Details

    - PMLiVE

    Innovative Trials

    Email
    Website

     Latest Content from  Innovative Trials 

    Lupus Awareness Month

    In this second October’s blog, we will be looking into Lupus in clinical trials: its symptoms, complications, treatments, incidence and focus on diversity.

    Black community representation in clinical trials

    This Black History Month, we discuss the black representation in clinical trials and the effects COVID-19 has had on the black community.

    Innovative Trials named Best global Patient Recruitment Company of 2021

    Innovative Trials, has been named Best Global Patient Recruitment Company by the Healthcare & Pharmaceutical Awards 2021.

    Queen’s Award Highlights Video

    Innovative Trials was awarded the Queen's Award for Enterprise, and this video includes highlights of the ceremony days at the HQ in Letchworth.

    Innovative Trials wins the Queen’s Award

    Innovative Trials presented with Queen’s Award for international excellence in clinical trial patient recruitment